University Emergency Hospital Bucharest, Romania
Search for other papers by Catalin Cirstoiu in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Bogdan Cretu in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Bogdan Serban in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Zsombor Panti in
Google Scholar
PubMed
University Emergency Hospital Bucharest, Romania
Search for other papers by Mihai Nica in
Google Scholar
PubMed
-
Modern surgical management of extremity bone sarcomas is governed by limb-sparing surgery combined with adjuvant and neoadjuvant chemotherapy.
-
All the resection and reconstruction techniques have to achieve oncologic excision margins, with survival rates and functional results superior to amputation.
-
The main reconstruction techniques of bone defects resulted after resection are: modular endoprosthetic reconstruction; bone graft reconstruction; bone transport; resection arthrodesis; and rotationplasty.
-
Oncologic resection and modular endoprosthetic reconstruction are the generally approved surgical options adopted for the majority of cases in major specialized bone sarcoma centres.
-
Good basic principles, efficient multidisciplinary approach and sustained research in the field can provide a better future for the challenge posed by extremity bone sarcoma treatment.
Cite this article: EFORT Open Rev 2019;4:174-182. DOI: 10.1302/2058-5241.4.180048
Search for other papers by Olga D. Savvidou in
Google Scholar
PubMed
Search for other papers by Panagiotis Koutsouradis in
Google Scholar
PubMed
Search for other papers by George D. Chloros in
Google Scholar
PubMed
Search for other papers by Ioannis Papanastasiou in
Google Scholar
PubMed
Search for other papers by Thomas Sarlikiotis in
Google Scholar
PubMed
Search for other papers by Aggelos Kaspiris in
Google Scholar
PubMed
Search for other papers by Panayiotis J. Papagelopoulos in
Google Scholar
PubMed
-
Bone tumours around the elbow are rare. Even nowadays diagnostic dilemmas and delays are common. During recent decades the management and prognosis of patients with elbow bone tumours has improved significantly.
-
Benign tumours can be treated using minimally invasive procedures, whereas malignant ones require a multidisciplinary team approach based on an adjuvant therapeutic regimen of chemotherapy, radiotherapy and limb salvage procedures.
-
This article reviews the most commonly encountered elbow bone tumours and their management.
Cite this article: EFORT Open Rev 2019;4:133-142. DOI: 10.1302/2058-5241.4.180086
Search for other papers by Maria Anna Smolle in
Google Scholar
PubMed
Search for other papers by Dimosthenis Andreou in
Google Scholar
PubMed
Search for other papers by Per-Ulf Tunn in
Google Scholar
PubMed
Search for other papers by Joanna Szkandera in
Google Scholar
PubMed
Search for other papers by Bernadette Liegl-Atzwanger in
Google Scholar
PubMed
Search for other papers by Andreas Leithner in
Google Scholar
PubMed
-
The relatively low incidence and often atypical clinical presentation of soft-tissue sarcomas (STS) impedes early and adequate diagnosis. Patients may report on recently enlarged soft-tissue swellings, infrequently complain of painful lesions, or even have no symptoms at all.
-
A thorough diagnostic work-up is essential in order to distinguish between benign soft-tissue tumours and STSs. Patient history, clinical features and radiological findings all help in assessing the underlying pathology. ‘Worrying’ features such as recent increase in size, deep location relative to the fascia, a tumour exceeding 4 cm in size, and invasive growth patterns seen on imaging should prompt verification by biopsy.
-
Even though acquisition of biopsy material may be incomplete, one should bear in mind some essential rules. Regardless of the biopsy technique applied, the most direct route to the lump in question should be identified, contamination of adjacent structures should be avoided and a sufficient amount of tissue acquired.
-
Treatment of STS is best planned by a multidisciplinary team, involving experts from various medical specialities. The benchmark therapy consists of en bloc resection of the tumour, covered by a safety margin of healthy tissue. Depending on tumour histology, grade, local extent and anatomical stage, radiotherapy, chemotherapy and isolated hyperthermic limb perfusion may be employed.
-
Due to the complexity of treatment, any soft-tissue swelling suspected of malignancy is best referred directly to a sarcoma centre, where therapeutic management is carefully planned by an experienced multidisciplinary team.
Cite this article: EFORT Open Rev 2017;2:421-431. DOI: 10.1302/2058-5241.2.170005
Search for other papers by Miklós Szendrői in
Google Scholar
PubMed
Search for other papers by Imre Antal in
Google Scholar
PubMed
Search for other papers by Attila Szendrői in
Google Scholar
PubMed
Search for other papers by Áron Lazáry in
Google Scholar
PubMed
Search for other papers by Péter Pál Varga in
Google Scholar
PubMed
-
Oncological management of skeletal metastases has changed dramatically in the last few decades. A significant number of patients survive for many years with their metastases.
-
Surgeons are more active and the technical repertoire is broader, from plates to intramedullary devices to (tumour) endoprostheses.
-
The philosophy of treatment should be different in the case of a trauma-related fracture and a pathological fracture. A proper algorithm for establishing a diagnosis and evaluation of prognostic factors helps in planning the surgical intervention.
-
The aim of palliative surgery is usually to eliminate pain and to allow the patient to regain his/her mobility as well as to improve the quality of life through minimally invasive techniques using life-long durable devices.
-
In a selected group of patients with an oncologically controlled primary tumour site and a solitary bone metastasis with positive prognostic factors, which meet the criteria for radical excision (approximately 10% to 15% of the cases), a promising three to five years of survival may be achieved, especially in cases of metastases from breast and kidney cancer.
-
Spinal metastases require meticulous evaluation because decisions on treatment mostly depend on the tumour type, segmental stability, the patient’s symptoms and general state of health.
-
Advanced radiotherapy combined with minimally invasive surgical techniques (minimally invasive stabilisation and separation surgery) provides durable local control with a low complication rate in a number of patients.
Cite this article: EFORT Open Rev 2017;2:372-381.
Search for other papers by James Plant in
Google Scholar
PubMed
Search for other papers by Stephen Cannon in
Google Scholar
PubMed
-
Benign abnormalities of bone are common, especially in children.
-
Malignant bone sarcomas are aggressive and have a poor outcome, particularly if treatment is delayed or initiated in a non-specialist centre.
-
Conversely, specialist tumour centres are overwhelmed with referrals for benign disease, a predictable outcome of an increasingly litigious medical environment. This review aims to arm the general orthopaedic surgeon or general practitioner with information to better discern a benign bone lesion from a malignant one, and explain the process of investigation and onward referral for those in whom malignant disease is suspected.
Cite this article: Plant J, Cannon S. Diagnostic work up and recognition of primary bone tumours: a review. EFORT Open Rev 2016;1:247-253. DOI: 10.1302/2058-5241.1.000035.
Search for other papers by Julie J. Willeumier in
Google Scholar
PubMed
Search for other papers by Yvette M. van der Linden in
Google Scholar
PubMed
Search for other papers by Michiel A.J. van de Sande in
Google Scholar
PubMed
Search for other papers by P.D. Sander Dijkstra in
Google Scholar
PubMed
-
Bone metastases of the long bones often lead to pain and pathological fractures. Local treatment consists of radiotherapy or surgery. Treatment strategies are strongly based on the risk of the fracture and expected survival.
-
Diagnostic work-up consists of CT and biopsy for diagnosis of the primary tumour, bone scan or PET-CT for dissemination status, patient history and blood test for evaluation of general health, and biplanar radiograph or CT for evaluation of the involved bone.
-
A bone lesion with an axial cortical involvement of >30 mm has a high risk of fracturing and should be stabilised surgically.
-
Expected survival should be based on primary tumour type, performance score, and presence of visceral and cerebral metastases.
-
Radiotherapy is the primary treatment for symptomatic lesions without risk of fracturing. The role of post-operative radiotherapy remains unclear.
-
Main surgical treatment options consist of plate fixation, intramedullary nails and (endo) prosthesis. The choice of modality depends on the localisation, extent of involved bone, and expected survival. Adjuvant cement should be considered in large lesions for better stabilisation.
Cite this article: Willeumier JJ, van der Linden YM, van de Sande MAJ, Dijkstra PDS. Treatment of pathological fractures of the long bones. EFORT Open Rev 2016;1:136–145. DOI: 10.1302/2058-5241.1.000008.
